{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:18:56Z","timestamp":1787019536849,"version":"build-2736575974"},"reference-count":33,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,22]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>In thalassemia patients with cardiac siderosis, amlodipine combined with iron chelation resulted in more effective reduction of cardiac iron. The combined treatment did not have any effect on serum ferritin and left ventricular ejection fraction.<\/jats:p>","DOI":"10.1182\/blood-2016-06-721183","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T03:08:33Z","timestamp":1468465713000},"page":"1555-1561","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":48,"title":["A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major"],"prefix":"10.1182","volume":"128","author":[{"given":"Juliano L.","family":"Fernandes","sequence":"first","affiliation":[{"name":"Jose Michel Kalaf Research Institute, Campinas, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R.","family":"Loggetto","sequence":"additional","affiliation":[{"name":"Centro de Hematologia de S\u00e3o Paulo, S\u00e3o Paulo, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica P. A.","family":"Ver\u00edssimo","sequence":"additional","affiliation":[{"name":"Centro Infantil de Investiga\u00e7\u00f5es Hematol\u00f3gicas Dr Domingos A Boldrini, Campinas, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleber Y.","family":"Fertrin","sequence":"additional","affiliation":[{"name":"University of Campinas, Campinas, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio R.","family":"Baldanzi","sequence":"additional","affiliation":[{"name":"Centro de Hematologia e Hemoterapia do Paran\u00e1, Curitiba, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana A. B.","family":"Fioravante","sequence":"additional","affiliation":[{"name":"Jose Michel Kalaf Research Institute, Campinas, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doralice M.","family":"Tan","sequence":"additional","affiliation":[{"name":"Marilia Medical School, Marilia, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Higa","sequence":"additional","affiliation":[{"name":"Maringa State University, Maringa, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.","family":"Mashima","sequence":"additional","affiliation":[{"name":"Londrina State University, Londrina, Brazil; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Piga","sequence":"additional","affiliation":[{"name":"University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio R.","family":"Coelho","sequence":"additional","affiliation":[{"name":"University of Campinas, Campinas, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando F.","family":"Costa","sequence":"additional","affiliation":[{"name":"University of Campinas, Campinas, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara T.","family":"Saad","sequence":"additional","affiliation":[{"name":"University of Campinas, Campinas, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111705034951700_B1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/ejh.12487","article-title":"Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study.","volume":"95","author":"Aydinok","year":"2015","journal-title":"Eur J Haematol"},{"issue":"9","key":"2019111705034951700_B2","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3324\/haematol.2013.083634","article-title":"International survey of T2* cardiovascular magnetic resonance in \u03b2-thalassemia major.","volume":"98","author":"Carpenter","year":"2013","journal-title":"Haematologica"},{"issue":"3","key":"2019111705034951700_B3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatment in \u03b2-thalassemia major: a consensus statement from the American Heart Association [published correction appears in Circulation 2013;128(3):e203].","volume":"128","author":"Pennell","year":"2013","journal-title":"Circulation"},{"issue":"20","key":"2019111705034951700_B4","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major.","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"issue":"10","key":"2019111705034951700_B5","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2013-04-497842","article-title":"A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in \u03b2-thalassemia major (CORDELIA).","volume":"123","author":"Pennell","year":"2014","journal-title":"Blood"},{"key":"2019111705034951700_B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-15-1","article-title":"Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy.","volume":"15","author":"Pepe","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2019111705034951700_B7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1532-429X-15-38","article-title":"Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone.","volume":"15","author":"Porter","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"2019111705034951700_B8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3324\/haematol.2010.031468","article-title":"Continued improvement in myocardial T2* over two years of deferasirox therapy in \u03b2-thalassemia major patients with cardiac iron overload.","volume":"96","author":"Pennell","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"2019111705034951700_B9","first-page":"108","article-title":"Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias.","volume":"11","author":"Viprakasit","year":"2013","journal-title":"Blood Transfus"},{"issue":"3","key":"2019111705034951700_B10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance.","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111705034951700_B11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.hoc.2014.04.003","article-title":"The pathophysiology of transfusional iron overload.","volume":"28","author":"Porter","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"2019111705034951700_B12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","article-title":"Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy.","volume":"84","author":"Oudit","year":"2006","journal-title":"J Mol Med (Berl)"},{"issue":"9","key":"2019111705034951700_B13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy.","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat Med"},{"issue":"6","key":"2019111705034951700_B14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-0609.2012.01779.x","article-title":"T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice.","volume":"88","author":"Kumfu","year":"2012","journal-title":"Eur J Haematol"},{"issue":"4","key":"2019111705034951700_B15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm1542","article-title":"Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1.","volume":"13","author":"Ludwiczek","year":"2007","journal-title":"Nat Med"},{"issue":"9","key":"2019111705034951700_B16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.amjmed.2013.05.002","article-title":"Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial.","volume":"126","author":"Fernandes","year":"2013","journal-title":"Am J Med"},{"issue":"6","key":"2019111705034951700_B17","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/jmri.20929","article-title":"Black-blood T2* technique for myocardial iron measurement in thalassemia.","volume":"25","author":"He","year":"2007","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"2019111705034951700_B18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0735-1097(02)02931-5","article-title":"Susceptibility-sensitive magnetic resonance imaging detects human myocardium supplied by a stenotic coronary artery without a contrast agent.","volume":"41","author":"Wacker","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2019111705034951700_B19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/nbm.1121","article-title":"Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts.","volume":"20","author":"Positano","year":"2007","journal-title":"NMR Biomed"},{"issue":"14","key":"2019111705034951700_B20","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2* magnetic resonance and cardiac iron.","volume":"123","author":"Carpenter","year":"2011","journal-title":"Circulation"},{"key":"2019111705034951700_B21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1532-429X-16-40","article-title":"Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan.","volume":"16","author":"Garbowski","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"issue":"12","key":"2019111705034951700_B22","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2009-04-217455","article-title":"Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia.","volume":"115","author":"Pennell","year":"2010","journal-title":"Blood"},{"issue":"9454","key":"2019111705034951700_B23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(05)17709-5","article-title":"Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"issue":"19","key":"2019111705034951700_B24","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs.","volume":"341","author":"Abernethy","year":"1999","journal-title":"N Engl J Med"},{"issue":"3-4","key":"2019111705034951700_B25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s004670000480","article-title":"Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension.","volume":"15","author":"Flynn","year":"2000","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"2019111705034951700_B26","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","article-title":"Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload.","volume":"84","author":"Tsushima","year":"1999","journal-title":"Circ Res"},{"issue":"1","key":"2019111705034951700_B27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00003088-199222010-00003","article-title":"Clinical pharmacokinetics of amlodipine.","volume":"22","author":"Meredith","year":"1992","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"2019111705034951700_B28","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.","volume":"107","author":"Pennell","year":"2006","journal-title":"Blood"},{"issue":"14","key":"2019111705034951700_B29","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"key":"2019111705034951700_B30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1532-429X-10-12","article-title":"Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.","volume":"10","author":"Tanner","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"issue":"9","key":"2019111705034951700_B31","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00277-012-1465-7","article-title":"A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births.","volume":"91","author":"Voskaridou","year":"2012","journal-title":"Ann Hematol"},{"key":"2019111705034951700_B32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12968-015-0207-0","article-title":"T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis.","volume":"17","author":"Alam","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"2019111705034951700_B33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ejh.12224","article-title":"History of myocardial iron loading is a strong risk factor for diabetes mellitus and hypogonadism in adults with \u03b2 thalassemia major.","volume":"92","author":"Ang","year":"2014","journal-title":"Eur J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/12\/1555\/1395938\/1555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/12\/1555\/1395938\/1555.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T05:04:03Z","timestamp":1573967043000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/12\/1555\/73123\/A-randomized-trial-of-amlodipine-in-addition-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,9,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-06-721183","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,22]]}}}